Formulary guidance and transparency from P&T to point of care


Reality Check on Asthma and COPD

Market access for respiratory treatments reveals differences in payer coverage across each major channel, as well as specific trends in the drug landscape.  

To help make sense of this new research, MMIT's team of experts has analyzed the data for you and summarized the key findings:

  • Payer Insights: Increasing percentage of restricted medicare lives on pharmacy benefit with a massive amount of covered lives restricted on payer-controlled medical benefits
  • Class Trends: How pricing and reimbursement impacts prescribers and patients.
  • Key Findings: How market entrants are expected to drive more payer contracting

What can pharma do to curb this trend and overcome these challenges?

Get the data behind this change and how it could impact your market access plans from MMIT's team.  Their clinical and policy backgrounds provide a unique and expert perspective to help expand your knowledge in the class and guide your decision-making process.

Download the full Reality Check now.